메뉴 건너뛰기




Volumn 55, Issue 19, 2012, Pages 8392-8408

2-(3-Fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: Structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3- ylmethyl) C-region

Author keywords

[No Author keywords available]

Indexed keywords

(2S) 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL) N ((2 (2 METHYLPYRROLIDIN 1 YL) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL)PROPANAMIDE; (S) 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL) N ((2 ((S) 2 (HYDROXYMETHYL)PYRROLIDIN 1 YL) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL)PROPANAMIDE; 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL) N ((2 ((4 FLUOROPHENYL)AMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL)PROPANAMIDE; 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL) N ((2 ((4 METHYLCYCLOHEXYL)AMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL)PROPANAMIDE; 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL) N ((2 ((PYRIDIN 2 YLMETHYL)AMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL)PROPANAMIDE; 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL) N ((2 ((PYRIDIN 3 YLMETHYL)AMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL)PROPANAMIDE; 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL) N ((2 ((PYRIDIN 4 YLMETHYL)AMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL)PROPANAMIDE; 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL) N ((2 (METHYL (PHENYL)AMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL)PROPANAMIDE; 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL) N ((2 (PHENYLAMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL)PROPANAMIDE; 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL) N ((2 (PYRROLIDIN 1 YL) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL)PROPANAMID; 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL) N ((6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL)PROPANAMIDE; 2 (3 FLUORO 4 METHYLSULFONYLAMINOPHENYL)PROPANAMIDE DERIVATIVE; CAPSAICIN; N ((2 ((3,4 DIMETHYLPHENYL)AMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL) 2 (3 FLUORO 4 (METHYLSULFONAMIDO) PHENYL)PROPANAMIDE; N ((2 ((4 CHLOROBENZYL)AMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL) 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL)PROPANAMIDE; N ((2 ((4 CHLOROPHENYL)AMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL) 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL)PROPANAMIDE; N ((2 ((5 CHLORO 2 METHYLPHENYL)AMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL) 2 (3 FLUORO 4 (METHYLSULFONAMIDO) PHENYL)PROPANAMIDE; N ((2 (BENZYLAMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL) METHYL) 2 (3 FLUORO 4 (METHYLSUL FONAMIDO)PHENYL)PROPANAMIDE; N ((2 (BUTYL(METHYL)AMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL) METHYL) 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL)PROPANAMIDE; N ((2 (BUTYLAMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL) 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL)PROPANAMIDE; N ((2 (CYCLOHEXYLAMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL) 2 (3 FLUORO 4 (METHYLSULFONAMIDO)PHENYL)PROPANAMIDE; N ((2 (DIBUTYLAMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL) 2 (3 FLUORO 4 (METHYLSUL FONAMIDO)PHENYL)PROPANAMIDE; N ((2 (DIETHYLAMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL) 2 (3 FLUORO 4 (METHYLSUL FONAMIDO)PHENYL)PROPANAMIDE; N ((2 (DIMETHYLAMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL) 2 (3 FLUORO 4 (METHYLSUL FONAMIDO)PHENYL)PROPANAMIDE; N ((2 (DIPROPYLAMINO) 6 (TRIFLUOROMETHYL)PYRIDIN 3 YL)METHYL) 2 (3 FLUORO 4 (METHYLSUL FONAMIDO)PHENYL)PROPANAMIDE; N (6 TRIFLUOROMETHYLPYRIDIN 3 YLMETHYL); PYRIDINE DERIVATIVE; TERT BUTYL 4 (((3 ((2 (3 FLUORO 4 (METHYLSULFONAMIDO) PHENYL)PROPANAMIDO)METHYL) 6 (TRIFLUOROMETHYL)PYRIDIN 2 YL) AMINO)METHYL)PIPERIDINE 1 CARBOXYLATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 1 ANTAGONIST;

EID: 84867340601     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm300780p     Document Type: Article
Times cited : (37)

References (27)
  • 1
    • 0032970173 scopus 로고    scopus 로고
    • Vanilloid (capsaicin) receptors and mechanisms
    • Szallasi, A.; Blumberg, P. M. Vanilloid (capsaicin) receptors and mechanisms Pharmacol. Rev. 1999, 51, 159-211
    • (1999) Pharmacol. Rev. , vol.51 , pp. 159-211
    • Szallasi, A.1    Blumberg, P.M.2
  • 7
    • 0031025655 scopus 로고    scopus 로고
    • Euphorbium: Modern research on its active principle, resiniferatoxin, revives an ancient medicine
    • Appendino, G.; Szallasi, A. Euphorbium: modern research on its active principle, resiniferatoxin, revives an ancient medicine Life Sci. 1997, 60, 681-696
    • (1997) Life Sci. , vol.60 , pp. 681-696
    • Appendino, G.1    Szallasi, A.2
  • 8
    • 33750358054 scopus 로고    scopus 로고
    • TRPV1: A therapeutic target for novel analgesic drugs?
    • Szallasi, A.; Cruz, F.; Geppetti, P. TRPV1: a therapeutic target for novel analgesic drugs? Trends Mol. Med. 2006, 12, 545-554
    • (2006) Trends Mol. Med. , vol.12 , pp. 545-554
    • Szallasi, A.1    Cruz, F.2    Geppetti, P.3
  • 9
    • 77955802570 scopus 로고    scopus 로고
    • Transient receptor potential vanilloid-1 antagonists: A survey of recent patent literature
    • Voight, E. A.; Kort, M. E. Transient receptor potential vanilloid-1 antagonists: a survey of recent patent literature Expert Opin. Ther. Pat. 2010, 20, 1-16
    • (2010) Expert Opin. Ther. Pat. , vol.20 , pp. 1-16
    • Voight, E.A.1    Kort, M.E.2
  • 11
    • 58149107126 scopus 로고    scopus 로고
    • Clinical development of TRPV1 antagonists: Targeting a pivotal point in the pain pathway
    • Gunthorpe, M. J.; Chizh, B. A. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway Drug Discovery Today 2009, 14, 56-67
    • (2009) Drug Discovery Today , vol.14 , pp. 56-67
    • Gunthorpe, M.J.1    Chizh, B.A.2
  • 12
    • 63649126112 scopus 로고    scopus 로고
    • Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks
    • Wong, G. Y.; Gavva, N. R. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: recent advances and setbacks Brain Res. Rev. 2009, 60, 267-277
    • (2009) Brain Res. Rev. , vol.60 , pp. 267-277
    • Wong, G.Y.1    Gavva, N.R.2
  • 16
    • 0037380947 scopus 로고    scopus 로고
    • Mol. Pharmacol. 2003, 63, 958
    • (2003) Mol. Pharmacol. , vol.63 , pp. 958
  • 19
    • 0023887324 scopus 로고
    • Synthesis of selectively trifluoromethylated pyridine derivatives as potential antihypertensives
    • Lang, R. W.; Wenk, P. F. Synthesis of selectively trifluoromethylated pyridine derivatives as potential antihypertensives Helv. Chim. Acta 1988, 71, 596-601
    • (1988) Helv. Chim. Acta , vol.71 , pp. 596-601
    • Lang, R.W.1    Wenk, P.F.2
  • 20
    • 0023895875 scopus 로고
    • A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
    • Bennett, G. J.; Xie, Y.-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man Pain 1988, 33, 87-107
    • (1988) Pain , vol.33 , pp. 87-107
    • Bennett, G.J.1    Xie, Y.-K.2
  • 22
    • 0024501543 scopus 로고
    • Thermoregulatory effects of resiniferatoxin in the mouse: Comparison with capsaicin
    • De Vries, D. J.; Blumberg, P. M. Thermoregulatory effects of resiniferatoxin in the mouse: comparison with capsaicin Life Sci. 1989, 44, 711-715
    • (1989) Life Sci. , vol.44 , pp. 711-715
    • De Vries, D.J.1    Blumberg, P.M.2
  • 25
    • 79956220949 scopus 로고    scopus 로고
    • Structural insights into transient receptor potential vanilloid type 1 (TRPV1) from homology modeling, flexible docking, and mutational studies
    • Lee, J. H.; Lee, Y.; Ryu, H.; Kang, D. W.; Lee, J.; Lazar, J.; Pearce, L. V; Pavlyukovets, V. A.; Blumberg, P. M.; Choi, S. Structural insights into transient receptor potential vanilloid type 1 (TRPV1) from homology modeling, flexible docking, and mutational studies J. Comput.-Aided Mol. Des. 2011, 25, 317-327
    • (2011) J. Comput.-Aided Mol. Des. , vol.25 , pp. 317-327
    • Lee, J.H.1    Lee, Y.2    Ryu, H.3    Kang, D.W.4    Lee, J.5    Lazar, J.6    Pearce, L.V.7    Pavlyukovets, V.A.8    Blumberg, P.M.9    Choi, S.10
  • 27
    • 0020525719 scopus 로고
    • Ethical guidelines for investigations of experimental pain in conscious animals
    • Zimmermann, M. Ethical guidelines for investigations of experimental pain in conscious animals Pain 1983, 16, 109-110
    • (1983) Pain , vol.16 , pp. 109-110
    • Zimmermann, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.